Bydureon BCise (eksenatyd)

Bydureon BCise (eksenatyd)
Bydureon BCise (Exenatide) is an injectable prescription medicine that may improve blood sugar (glucose) in adults and children ages 10 years and older with type 2 diabetes mellitus, Exenatide is in a class of medications called incretin mimetics. It works by stimulating the pancreas to secrete insulin when blood sugar levels are high. Insulin helps move sugar from the blood into other body tissues where it is used for energy. Exenatide also slows the emptying of the stomach and causes a decrease in appetite. It is not used instead of insulin to treat people with diabetes who need insulin.
Do not use Bydureon, Bydureon Bcise, Byetta or other medicines containing exenatide together. It is not known if Bydureon BCise can be used in people with a history of pancreatitis. Exenatide immediate-release (Byetta®) comes as a solution (liquid) in a prefilled dosing pen to inject subcutaneously (just under the skin). Exenatide extended-release (long-acting) (Bydureon® BCISE) comes as a suspension (liquid) in a prefilled autoinjector to inject subcutaneously.
You may change the day of the week that you use exenatide extended-release suspension if it has been 3 or more days since you used your last dose. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Use exenatide injection products exactly as directed. Do not use more or less of it or use it more often than prescribed by your doctor.
If you are changing from exenatide immediate-release solution to exenatide extended-release suspension, your glucose (sugar) levels may temporarily increase for 2 to 4 weeks after this change. Exenatide controls diabetes but does not cure it. Continue to use exenatide even if you feel well. Do not stop using exenatide without talking to your doctor. Follow these directions carefully.